Resource Logo
Being Alive

MUCH ADO ABOUT THE CONCORDE: European Study Raises New Questions About AZT


Being Alive 1993 May 5: 1

The airwaves were flooded in early April with news and interpretations of preliminary results from a large European study of early vs. later use of AZT. The study, a British-French-Irish collaboration known as the Concorde, began in October 1988 and involved 1749 HIV+ individuals, 15% of them women. The study was designed to determine whether beginning AZT therapy immediately, regardless of CD4 (T-helper cell) count, is associated with longer survival and a longer time before an AIDS diagnosis or the development of symptoms, when compared to a policy of waiting to begin AZT until one has developed some symptoms or until one's CD4 count has begun to sharply drop. 


Information in this article was accurate in May 5, 1993. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.